Melanoma Metabolism: Cell Survival and Resistance to Therapy
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-34025-4_11
Reference158 articles.
1. Abildgaard C, Guldberg P (2015) Molecular drivers of cellular metabolic reprogramming in melanoma. Trends Mol Med 21:164–171. https://doi.org/10.1016/j.molmed.2014.12.007
2. Aiderus A, Black MA, Dunbier AK (2018) Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers. BMC Cancer 18:1–15. https://doi.org/10.1186/s12885-018-4626-9
3. Alegre ML, Frauwirth KA, Thompson CB et al (2000) Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J Immunol 168:5070–5078. https://doi.org/10.4049/jimmunol.168.10.5070
4. Ali Z, Yousaf N, Larkin J (2013) Melanoma epidemiology, biology and prognosis. Eur J Cancer Suppl 11:81–91. https://doi.org/10.1016/j.ejcsup.2013.07.012
5. Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–1075. https://doi.org/10.1016/S0140-6736(17)33326-3
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lectin-glycan interactions: a comprehensive cataloguing of cancer-associated glycans for biorecognition and bio-alteration: a review;Glycoconjugate Journal;2024-09-02
2. Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma;Biochemical Pharmacology;2024-05
3. BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02
4. Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR‐487a‐5p promotes melanoma oligo‐ to poly‐metastatic progression;Molecular Oncology;2023-07
5. Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment;Cancers;2023-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3